Sprycel and fluid retention Patient Reports February 11, 2012

Sprycel Side Effects Report #5518517-5
Sprycel side effect was reported by a Physician from SPAIN on Nov 08, 2007. Female patient, 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: atrioventricular block complete, dyspnoea, fluid retention. Sprycel dosage: 15-MAY-2007 TO 25-MAY-2007 - 140 MG, RESTARTED ON 03 JULY 2007.. During the same period patient was treated with ZANIDIP, DIANBEN, GLIMEPIRIDE, DABONAL PLUS, MIXTARD, CARDURA NEO, SEGURIL. Patient recovered.

Sprycel Side Effects Report #5526322-9
Sprycel side effect was reported by a Physician from SPAIN on Nov 19, 2007. Female patient, 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: atrioventricular block complete, cardiac failure congestive, dyspnoea, fluid retention, pleural effusion. Sprycel dosage: 15-MAY-2007 TO 25-MAY-2007 - 140 MG, RESTARTED ON 03 JULY 2007.. During the same period patient was treated with ZANIDIP, DIANBEN, GLIMEPIRIDE, DABONAL PLUS, MIXTARD, CARDURA NEO, SEGURIL. Patient recovered.

Sprycel Side Effects Report #5336459-5
Sprycel side effect was reported by a Physician from GERMANY on May 24, 2007. Female patient, 71 years of age, weighting 152.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: anaemia, epidermolysis, fluid retention, pancytopenia, renal pain, thrombocytopenia. Sprycel dosage: unknown. Patient recovered.

Sprycel Side Effects Report #5354138-5
Sprycel side effect was reported by a Physician from GERMANY on June 08, 2007. Female patient, 71 years of age, weighting 152.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: anaemia, epidermolysis, fluid retention, pancytopenia, renal pain, thrombocytopenia. Sprycel dosage: unknown. Patient recovered.


Sprycel Side Effects Report #5369035-9
Sprycel side effect was reported by a Physician from GERMANY on June 20, 2007. Female patient, 71 years of age, weighting 152.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: anaemia, epidermolysis, fluid retention, pancytopenia, renal pain, thrombocytopenia. Sprycel dosage: unknown. Patient recovered.

Sprycel Side Effects Report #5436959-3
Sprycel side effect was reported by a Consumer or non-health professional from CZECH REPUBLIC on Aug 28, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: atrial flutter, atrioventricular block second degree, cardiopulmonary failure, erysipelas, fluid retention, hypertension, weight increased. Sprycel dosage: unknown. During the same period patient was treated with MILURIT, FURON, ZYRTEC, TENORMIN. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5571628-0
Sprycel side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2007. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: fluid retention, pulmonary oedema. Sprycel dosage: unknown. Patient recovered.

Sprycel Side Effects Report #5636754-6
Sprycel side effect was reported by a Consumer or non-health professional from CZECH REPUBLIC on Feb 20, 2008. Male patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: atrial flutter, atrioventricular block second degree, cardiopulmonary failure, erysipelas, fluid retention, hypertension, weight increased. Sprycel dosage: unknown. During the same period patient was treated with MILURIT, FURON, ZYRTEC, TENORMIN. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5469818-0
Sprycel side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Female patient, 62 years of age, was diagnosed with chronic myeloid leukaemia, neuropathy peripheral and was treated with Sprycel. After drug was administered, patient experienced the following side effects: convulsion, fluid retention, herpes zoster. Sprycel dosage: THE DOSE OF DASATINIB WAS INCREASED TO 70 MG, BUT WHEN IS NOT SPECIFIED.. During the same period patient was treated with TOPROL, LASIX, SINGULAIR, FLONASE, ALBUTEROL, LEXAPRO, CELEBREX, NEURONTIN. Patient was hospitalized and became disabled. Patient recovered.


Sprycel Side Effects Report #5279138-5
Sprycel side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2006. Female patient, 56 years of age, weighting 220.5 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: dyspnoea exertional, fluid retention, headache . Sprycel dosage: unknown. During the same period patient was treated with ZOLOFT, SYNTHROID, VITAMIN E, NASONEX, ESTRATEST, MUCINEX, DYAZIDE. Patient recovered.

Sprycel Side Effects Report #5494354-5
Sprycel side effect was reported by a Physician from SPAIN on Oct 19, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: atrioventricular block complete, dyspnoea, fluid retention. Sprycel dosage: 15-MAY-2007 TO 25-MAY-2007 - 140 MG, RESTARTED ON 03 JULY 2007.. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, FUROSEMIDE, ENALAPRIL MALEATE, INSULIN. Patient recovered.

Sprycel Side Effects Report #5503818-7
Sprycel side effect was reported by a Physician from SPAIN on Oct 29, 2007. Female patient was diagnosed with chronic myeloid leukaemia and was treated with Sprycel. After drug was administered, patient experienced the following side effects: atrioventricular block complete, dyspnoea, fluid retention. Sprycel dosage: 15-MAY-2007 TO 25-MAY-2007 - 140 MG, RESTARTED ON 03 JULY 2007.. During the same period patient was treated with ZANIDIP, METFORMIN, GLIMEPIRIDE, FUROSEMIDE, ENALAPRIL MALEATE, INSULIN. Patient recovered.